{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:43:29Z","timestamp":1783568609349,"version":"3.55.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012818","name":"Community of Madrid","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023961","name":"Centro de Investigaci\u00f3n Biotecnol\u00f3gica en Red de Enfermedades Infecciosas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["MPY380\/18"],"award-info":[{"award-number":["MPY380\/18"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jgar.2025.07.020","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T06:54:43Z","timestamp":1753253683000},"page":"366-370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Activity of LpxC inhibitors on carbapenemase-producing Citrobacter spp. clinical isolates"],"prefix":"10.1016","volume":"44","author":[{"given":"V\u00edctor","family":"Vinuesa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Cruces","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier E.","family":"Ca\u00f1ada-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Oteo-Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Corral-Lugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"McConnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2025.07.020_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.737636","article-title":"Antimicrobial resistance and molecular characterization of Citrobacter spp. Causing extraintestinal infections","volume":"11","author":"Liu","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jgar.2025.07.020_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.744431","article-title":"Carbapenem-resistant Citrobacter spp. As an emerging concern in the hospital-setting: results from a genome-based regional surveillance study","volume":"11","author":"Yao","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jgar.2025.07.020_bib0003","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1093\/jac\/dkx325","article-title":"Spanish Antibiotic Resistance Surveillance Programme Collaborating Group. Carbapenem-resistant Citrobacter spp. Isolated in Spain from 2013 to 2015 produced a variety of carbapenemases including VIM-1, OXA-48, KPC-2, NDM-1 and VIM-2","volume":"72","author":"Arana","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2025.07.020_bib0004","doi-asserted-by":"crossref","first-page":"e714","DOI":"10.1016\/j.ijid.2013.02.007","article-title":"Outbreak of Citrobacter freundii carrying VIM-1 in an Italian hospital, identified during the carbapenemases screening actions, June 2012","volume":"17","author":"Gaibani","year":"2013","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jgar.2025.07.020_bib0005","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ijantimicag.2008.05.008","article-title":"First identification of VIM-1-producing Citrobacter freundii in Greece","volume":"32","author":"Protonotariou","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2025.07.020_bib0006","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00275-20","article-title":"Clinical and genomic epidemiology of carbapenem-nonsusceptible Citrobacter spp. At a tertiary health care center over 2 decades","volume":"58","author":"Babiker","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2025.07.020_bib0007","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1021\/jm2014748","article-title":"Potent inhibitors of LpxC for the treatment of gram-negative infections","volume":"55","author":"Brown","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.jgar.2025.07.020_bib0008","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1126\/science.274.5289.980","article-title":"Antibacterial agents that inhibit lipid A biosynthesis","volume":"274","author":"Onishi","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.jgar.2025.07.020_bib0009","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01934-17","article-title":"CLSI Methods Development and Standardization Working Group of the Subcommittee on Antimicrobial susceptibility testing. CLSI Methods Development and Standardization Working Group Best practices for evaluation of antimicrobial susceptibility tests","volume":"56","author":"Humphries","year":"2018","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2025.07.020_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115326","article-title":"Small molecule LpxC inhibitors against gram-negative bacteria: advances and future perspectives","volume":"253","author":"Niu","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jgar.2025.07.020_bib0011","doi-asserted-by":"crossref","first-page":"18433","DOI":"10.1073\/pnas.0709412104","article-title":"Structure of the deacetylase LpxC bound to the antibiotic CHIR-090: time-dependent inhibition and specificity in ligand binding","volume":"104","author":"Barb","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jgar.2025.07.020_bib0012","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1021\/jm2014748","article-title":"Potent inhibitors of LpxC for the treatment of gram-negative infections","volume":"55","author":"Brown","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.jgar.2025.07.020_bib0013","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1080\/13543776.2017.1360282","article-title":"LpxC inhibitors: a patent review (2010\u20132016)","volume":"27","author":"Kalinin","year":"2017","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.jgar.2025.07.020_bib0014","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1126\/science.274.5289.980","article-title":"Antibacterial agents that inhibit lipid A biosynthesis","volume":"274","author":"Onishi","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.jgar.2025.07.020_bib0015","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00977-19","article-title":"Potent LpxC inhibitors with in vitro activity against multidrug-resistant Pseudomonas aeruginosa","volume":"63","author":"Krause","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2025.07.020_bib0016","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01551-14","article-title":"LpxC inhibitors as new antibacterial agents and tools for studying regulation of lipid A biosynthesis in gram-negative pathogens","volume":"5","author":"Tomaras","year":"2014","journal-title":"MBio"},{"key":"10.1016\/j.jgar.2025.07.020_bib0017","doi-asserted-by":"crossref","first-page":"5002","DOI":"10.1021\/acs.jmedchem.7b00377","article-title":"Design, synthesis, and properties of a potent inhibitor of Pseudomonas aeruginosa deacetylase LpxC","volume":"60","author":"Piizzi","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.jgar.2025.07.020_bib0018","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1021\/bi6025165","article-title":"Inhibition of lipid A biosynthesis as the primary mechanism of CHIR-090 antibiotic activity in Escherichia coli","volume":"46","author":"Barb","year":"2007","journal-title":"Biochemistry"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371652500178X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371652500178X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T07:19:45Z","timestamp":1777101585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221371652500178X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":18,"alternative-id":["S221371652500178X"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2025.07.020","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activity of LpxC inhibitors on carbapenemase-producing Citrobacter spp. clinical isolates","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2025.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}